OverviewChartNewsTraderScreen

Soc. Generale Knock-Out AZN/  DE000SW8GHV2  /

EUWAX
6/28/2024  8:10:16 AM Chg.-0.08 Bid10:00:46 PM Ask10:00:46 PM Underlying Strike price Expiration date Option type
1.15EUR -6.50% -
Bid Size: -		 -
Ask Size: -		 AstraZeneca PLC 1,401.016 SEK 12/31/2078 Call
GlobeNewswire 6/26 As the PNH Market Continues to Crowd, Spherix Announces New Suite of Advisory Services to Explore Co...
GlobeNewswire 6/20 Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Gr...
GlobeNewswire 6/18 Mika Health Collaborates with AstraZeneca and Daiichi Sankyo to Deliver AI-Enabled Mobile Support to...
GlobeNewswire 6/18 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire 6/13 Rheumatologists' Aggressive Approach to SLE Treatment Targets Specific Patient Types with Biologics
GlobeNewswire 5/28 Cellectis Reports Financial Results for First Quarter 2024
TeleTrader 5/21 AstraZeneca to deliver $80B total revenue by 2030
TeleTrader 5/20 AstraZeneca to build $1.5B plant in Singapore
GlobeNewswire 5/8 Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire 5/8 Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire 5/6 FibroGen Reports First Quarter 2024 Financial Results
GlobeNewswire 5/6 Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire 4/29 Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
TeleTrader 4/25 Europe opens mostly down after corporate earnings
TeleTrader 4/25 AstraZeneca Q1 revenue jumps 19% to $12.7B
GlobeNewswire 4/1 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent ...
GlobeNewswire 3/28 HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
GlobeNewswire 3/19 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Phar...
TeleTrader 3/19 AstraZeneca to acquire Fusion for $2 billion
GlobeNewswire 3/18 AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement
TeleTrader 3/14 AstraZeneca to acquire Amolyt Pharma for $1.05B
GlobeNewswire 3/14 Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
GlobeNewswire 2/28 HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
GlobeNewswire 2/26 FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 2/26 FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...